{"id":196635,"name":"MILANAPHARM","slug":"milanapharm","state":"AL","country":"United States of America","description":"Specialty pharmaceutical company with a proprietary drug delivery platform","totalSpending":0,"filings":29,"yearlySpending":[{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["FORBES-TATE"],"lobbyists":["ZACHARY WILLIAMS","WESLEY WELCH","EDWARD RENO","DERRICK WHITE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to the opioid crisis","Issues related to the opioid crisis. Issues related to NIH funding. Issues related to FY 2020 Appropriations; Issues related to defense funding. Issues related to wound care.","Issues related to the opioid crisis. Issues related to NIH funding. Issues related to FY 2020 Appropriations; Issues related to defense funding, including H.R. 2968 - Department of Defense Appropriati","Issues related to the opioid crisis. Issues related to NIH funding. Issues related to FY 2020 Appropriations; Issues related to defense funding, including H.R. 2968/S. 2474 - Department of Defense App","Issues related to the opioid crisis; Issues related to NIH funding; Issues related to wound care; Issues related to FY 2020 Appropriations and Defense funding, including H.R. 2968/S. 2474 - Department"]}